Condition: Radiation Retinopathy · Visual Impairment · Sponsor: Jaeb Center for Health Research
This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma with iodine-125 plaque brachytherapy.
This description comes directly from the study's public registry record.
Cynthia Stockdale, MPH · 8139758690 · DRCRNET@JAEB.ORG
Always discuss trial participation with your own doctor first.
| Byers Eye Institute at Stanford University | Palo Alto, California, United States | Recruiting |
| Retina Consultants | Manchester, Connecticut, United States | Recruiting |
| Retina Associates of Florida, LLC | Tampa, Florida, United States | Recruiting |
| Emory Eye Center | Atlanta, Georgia, United States | Recruiting |
| Northwestern Memorial Group | Chicago, Illinois, United States | Recruiting |
| IL Eye and Ear Infirmary-University of Illinois at Chicago | Chicago, Illinois, United States | Recruiting |
| Midwest Eye Institute | Indianapolis, Indiana, United States | Recruiting |
| University of Iowa Department of Ophthalmology and Visual Sciences | Iowa City, Iowa, United States | Recruiting |
| Foundation for Vision Research and Retina Specialists of Michigan, P.C. | Grand Rapids, Michigan, United States | Recruiting |
| Associated Retinal Consultants, P.C. | Royal Oak, Michigan, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Washington University Ophthalmology | St Louis, Missouri, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05844982